Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0005783 | endoplasmic reticulum | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4HH64
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004518 | nuclease activity | 4 | 1 |
GO:0004527 | exonuclease activity | 5 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 142 | 146 | PF00656 | 0.465 |
CLV_NRD_NRD_1 | 18 | 20 | PF00675 | 0.516 |
CLV_NRD_NRD_1 | 227 | 229 | PF00675 | 0.276 |
CLV_NRD_NRD_1 | 285 | 287 | PF00675 | 0.407 |
CLV_NRD_NRD_1 | 342 | 344 | PF00675 | 0.473 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.450 |
CLV_PCSK_KEX2_1 | 285 | 287 | PF00082 | 0.383 |
CLV_PCSK_KEX2_1 | 303 | 305 | PF00082 | 0.389 |
CLV_PCSK_KEX2_1 | 341 | 343 | PF00082 | 0.472 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.462 |
CLV_PCSK_PC1ET2_1 | 303 | 305 | PF00082 | 0.454 |
CLV_PCSK_PC1ET2_1 | 341 | 343 | PF00082 | 0.476 |
CLV_PCSK_PC1ET2_1 | 6 | 8 | PF00082 | 0.458 |
CLV_PCSK_SKI1_1 | 167 | 171 | PF00082 | 0.247 |
DEG_APCC_DBOX_1 | 356 | 364 | PF00400 | 0.401 |
DEG_SCF_FBW7_1 | 127 | 134 | PF00400 | 0.534 |
DOC_MAPK_gen_1 | 228 | 234 | PF00069 | 0.473 |
DOC_MAPK_gen_1 | 352 | 360 | PF00069 | 0.536 |
DOC_MAPK_MEF2A_6 | 214 | 223 | PF00069 | 0.522 |
DOC_MAPK_MEF2A_6 | 354 | 362 | PF00069 | 0.461 |
DOC_USP7_MATH_1 | 146 | 150 | PF00917 | 0.564 |
DOC_USP7_UBL2_3 | 11 | 15 | PF12436 | 0.622 |
DOC_WW_Pin1_4 | 127 | 132 | PF00397 | 0.498 |
LIG_14-3-3_CanoR_1 | 113 | 118 | PF00244 | 0.453 |
LIG_14-3-3_CanoR_1 | 208 | 212 | PF00244 | 0.442 |
LIG_14-3-3_CanoR_1 | 250 | 254 | PF00244 | 0.511 |
LIG_14-3-3_CanoR_1 | 342 | 348 | PF00244 | 0.567 |
LIG_14-3-3_CanoR_1 | 357 | 361 | PF00244 | 0.371 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.719 |
LIG_BIR_III_2 | 145 | 149 | PF00653 | 0.536 |
LIG_deltaCOP1_diTrp_1 | 176 | 184 | PF00928 | 0.425 |
LIG_FHA_1 | 106 | 112 | PF00498 | 0.536 |
LIG_FHA_1 | 149 | 155 | PF00498 | 0.467 |
LIG_FHA_1 | 321 | 327 | PF00498 | 0.606 |
LIG_FHA_1 | 357 | 363 | PF00498 | 0.323 |
LIG_FHA_1 | 384 | 390 | PF00498 | 0.439 |
LIG_FHA_1 | 63 | 69 | PF00498 | 0.661 |
LIG_FHA_2 | 59 | 65 | PF00498 | 0.763 |
LIG_LIR_Apic_2 | 119 | 123 | PF02991 | 0.442 |
LIG_LIR_Gen_1 | 199 | 207 | PF02991 | 0.455 |
LIG_LIR_Gen_1 | 365 | 374 | PF02991 | 0.197 |
LIG_LIR_Gen_1 | 74 | 83 | PF02991 | 0.445 |
LIG_LIR_Nem_3 | 116 | 120 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 180 | 184 | PF02991 | 0.452 |
LIG_LIR_Nem_3 | 199 | 205 | PF02991 | 0.380 |
LIG_LIR_Nem_3 | 309 | 313 | PF02991 | 0.583 |
LIG_LIR_Nem_3 | 365 | 369 | PF02991 | 0.455 |
LIG_LIR_Nem_3 | 74 | 78 | PF02991 | 0.486 |
LIG_MYND_1 | 127 | 131 | PF01753 | 0.471 |
LIG_Pex14_2 | 197 | 201 | PF04695 | 0.442 |
LIG_SH2_PTP2 | 120 | 123 | PF00017 | 0.380 |
LIG_SH2_PTP2 | 75 | 78 | PF00017 | 0.503 |
LIG_SH2_SRC | 204 | 207 | PF00017 | 0.492 |
LIG_SH2_SRC | 75 | 78 | PF00017 | 0.537 |
LIG_SH2_STAT3 | 29 | 32 | PF00017 | 0.742 |
LIG_SH2_STAT3 | 373 | 376 | PF00017 | 0.355 |
LIG_SH2_STAT5 | 120 | 123 | PF00017 | 0.380 |
LIG_SH2_STAT5 | 204 | 207 | PF00017 | 0.442 |
LIG_SH2_STAT5 | 310 | 313 | PF00017 | 0.610 |
LIG_SH2_STAT5 | 373 | 376 | PF00017 | 0.334 |
LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.712 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.485 |
LIG_SH3_3 | 192 | 198 | PF00018 | 0.460 |
LIG_SUMO_SIM_anti_2 | 359 | 365 | PF11976 | 0.323 |
LIG_SUMO_SIM_anti_2 | 74 | 80 | PF11976 | 0.442 |
LIG_SUMO_SIM_par_1 | 102 | 108 | PF11976 | 0.453 |
LIG_SUMO_SIM_par_1 | 359 | 365 | PF11976 | 0.346 |
LIG_SUMO_SIM_par_1 | 74 | 80 | PF11976 | 0.442 |
LIG_TYR_ITIM | 200 | 205 | PF00017 | 0.442 |
LIG_WRC_WIRS_1 | 363 | 368 | PF05994 | 0.197 |
MOD_CK1_1 | 116 | 122 | PF00069 | 0.456 |
MOD_CK1_1 | 387 | 393 | PF00069 | 0.502 |
MOD_CK1_1 | 396 | 402 | PF00069 | 0.499 |
MOD_CK1_1 | 42 | 48 | PF00069 | 0.791 |
MOD_CK2_1 | 146 | 152 | PF00069 | 0.484 |
MOD_GlcNHglycan | 239 | 242 | PF01048 | 0.252 |
MOD_GlcNHglycan | 288 | 292 | PF01048 | 0.442 |
MOD_GlcNHglycan | 386 | 389 | PF01048 | 0.593 |
MOD_GlcNHglycan | 399 | 402 | PF01048 | 0.570 |
MOD_GlcNHglycan | 41 | 44 | PF01048 | 0.555 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.579 |
MOD_GSK3_1 | 127 | 134 | PF00069 | 0.550 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.745 |
MOD_GSK3_1 | 383 | 390 | PF00069 | 0.480 |
MOD_GSK3_1 | 393 | 400 | PF00069 | 0.376 |
MOD_GSK3_1 | 42 | 49 | PF00069 | 0.710 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.768 |
MOD_LATS_1 | 328 | 334 | PF00433 | 0.683 |
MOD_NEK2_1 | 394 | 399 | PF00069 | 0.339 |
MOD_NEK2_2 | 168 | 173 | PF00069 | 0.496 |
MOD_PIKK_1 | 131 | 137 | PF00454 | 0.483 |
MOD_PKA_1 | 341 | 347 | PF00069 | 0.602 |
MOD_PKA_2 | 161 | 167 | PF00069 | 0.469 |
MOD_PKA_2 | 207 | 213 | PF00069 | 0.442 |
MOD_PKA_2 | 249 | 255 | PF00069 | 0.408 |
MOD_PKA_2 | 34 | 40 | PF00069 | 0.695 |
MOD_PKA_2 | 341 | 347 | PF00069 | 0.593 |
MOD_PKA_2 | 356 | 362 | PF00069 | 0.502 |
MOD_Plk_4 | 116 | 122 | PF00069 | 0.536 |
MOD_Plk_4 | 168 | 174 | PF00069 | 0.553 |
MOD_Plk_4 | 196 | 202 | PF00069 | 0.463 |
MOD_Plk_4 | 356 | 362 | PF00069 | 0.536 |
MOD_Plk_4 | 390 | 396 | PF00069 | 0.329 |
MOD_Plk_4 | 42 | 48 | PF00069 | 0.712 |
MOD_ProDKin_1 | 127 | 133 | PF00069 | 0.498 |
MOD_SUMO_rev_2 | 176 | 184 | PF00179 | 0.442 |
TRG_ENDOCYTIC_2 | 202 | 205 | PF00928 | 0.451 |
TRG_ENDOCYTIC_2 | 310 | 313 | PF00928 | 0.594 |
TRG_ENDOCYTIC_2 | 75 | 78 | PF00928 | 0.525 |
TRG_ER_diArg_1 | 284 | 286 | PF00400 | 0.561 |
TRG_ER_diArg_1 | 352 | 355 | PF00400 | 0.485 |
TRG_NES_CRM1_1 | 70 | 82 | PF08389 | 0.498 |
TRG_NLS_MonoExtC_3 | 14 | 19 | PF00514 | 0.670 |
TRG_NLS_MonoExtN_4 | 3 | 10 | PF00514 | 0.749 |
TRG_Pf-PMV_PEXEL_1 | 346 | 351 | PF00026 | 0.379 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILS5 | Leptomonas seymouri | 75% | 99% |
A0A1X0P115 | Trypanosomatidae | 57% | 100% |
A0A3R7MWK6 | Trypanosoma rangeli | 59% | 100% |
A0A3S7X264 | Leishmania donovani | 87% | 100% |
A4I4A8 | Leishmania infantum | 87% | 100% |
C9ZKL9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 57% | 90% |
E9ADQ8 | Leishmania major | 86% | 100% |
E9AM22 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
V5BUL7 | Trypanosoma cruzi | 57% | 100% |